ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 17 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Looks Forward to Bolivia Presidential Runoff, Hoping for Increased Foreign Investment Support
Bolivia heads into an October presidential runoff, signaling a possible shift toward more pro-business policies,…
-
Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF): Building Value Through Nevada’s Walker Lane
Four-property portfolio in Nevada’s Walker Lane anchored by the Santa Fe Mine project with over…
-
ONAR Holding Corp. (ONAR) Powers Smarter Marketing with Agency Innovation
As budgets tighten and demands intensify, CMOs are questioning traditional marketing models ONAR is seizing…